Cutaneous T-cell lymphoma (CTCL) is a rare, chronic, and potentially progressive cancer affecting the skin’s T-cells, resulting in scaly rashes, patches, and tumors.
Hyperbaric oxygen therapy may enhance the effectiveness of cancer treatments in Cutaneous T-cell lymphoma by promoting better perfusion and oxygenation of affected tissues, ultimately improving the healing process.